OP Asset Management Ltd Purchases New Shares in Chemed Corporation $CHE

OP Asset Management Ltd acquired a new position in Chemed Corporation (NYSE:CHE) during the first quarter, according to the company in its most recent filing with the SEC. The fund acquired 15,925 shares of the company’s stock, valued at approximately $6,016,000. OP Asset Management Ltd owned approximately 0.11% of Chemed at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the company. SG Americas Securities LLC increased its holdings in Chemed by 773.5% during the 4th quarter. SG Americas Securities LLC now owns 26,466 shares of the company’s stock worth $11,324,000 after purchasing an additional 23,436 shares during the last quarter. Intech Investment Management LLC purchased a new position in shares of Chemed during the 3rd quarter valued at approximately $1,429,000. BNP Paribas Financial Markets boosted its stake in shares of Chemed by 14.5% during the 4th quarter. BNP Paribas Financial Markets now owns 35,024 shares of the company’s stock valued at $14,985,000 after buying an additional 4,430 shares during the last quarter. Bahl & Gaynor Inc. grew its position in shares of Chemed by 15.4% during the third quarter. Bahl & Gaynor Inc. now owns 20,042 shares of the company’s stock worth $8,974,000 after buying an additional 2,673 shares in the last quarter. Finally, Abacus FCF Advisors LLC acquired a new stake in shares of Chemed during the fourth quarter worth approximately $5,935,000. Institutional investors and hedge funds own 95.85% of the company’s stock.

Insider Activity

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction dated Friday, May 1st. The shares were sold at an average price of $421.13, for a total transaction of $842,260.00. Following the completion of the sale, the chief executive officer owned 90,219 shares of the company’s stock, valued at $37,993,927.47. This represents a 2.17% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Andrea R. Lindell sold 1,347 shares of the stock in a transaction dated Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total transaction of $602,553.51. Following the sale, the director owned 4,578 shares in the company, valued at approximately $2,047,876.74. This trade represents a 22.73% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 3.33% of the company’s stock.

Analyst Ratings Changes

CHE has been the subject of a number of research analyst reports. Wall Street Zen lowered shares of Chemed from a “buy” rating to a “hold” rating in a research note on Monday, June 8th. Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Weiss Ratings raised shares of Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, April 29th. Oppenheimer dropped their target price on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a research report on Friday, February 27th. Finally, Royal Bank Of Canada increased their price target on shares of Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a research report on Monday, April 27th. Two research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, Chemed presently has an average rating of “Hold” and a consensus price target of $501.50.

Chemed Stock Performance

CHE stock opened at $453.10 on Friday. The company has a current ratio of 0.85, a quick ratio of 0.83 and a debt-to-equity ratio of 0.11. The firm has a market cap of $6.01 billion, a P/E ratio of 24.69, a P/E/G ratio of 1.68 and a beta of 0.54. Chemed Corporation has a 12-month low of $365.20 and a 12-month high of $562.77. The stock’s 50 day simple moving average is $424.73 and its 200 day simple moving average is $424.70.

Chemed (NYSE:CHE) last announced its quarterly earnings data on Thursday, April 23rd. The company reported $5.65 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.30 by $0.35. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The firm had revenue of $657.51 million for the quarter, compared to analysts’ expectations of $659.22 million. During the same period last year, the business posted $5.63 earnings per share. The firm’s revenue for the quarter was up 1.6% on a year-over-year basis. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. As a group, equities research analysts predict that Chemed Corporation will post 22.3 EPS for the current year.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th were issued a $0.60 dividend. The ex-dividend date of this dividend was Thursday, May 28th. This represents a $2.40 annualized dividend and a dividend yield of 0.5%. Chemed’s payout ratio is 13.08%.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.